Patients with hepatitis C lost to follow-up: ethical-legal aspects and search results

Lost to follow-up.

results gained from primary attenders at a tate review clinic after shoulder surgery may not be representative of the outcome: the average self-assessment of the non-attenders was lower by one class. Age differences have been shown to affect the self assessment of health (Idler 1993). In this study, however, with an average age of 5 1.1 years among attenders and 48.8 years in non-attenders, thi...

The follow-up results with sustained virologic response in chronic hepatitis C patients in Şanlıurfa/Turkey

Objectives: The aim of the study was to evaluate sustained virological response (SVR) after treatment and factors that influence SVR among patients treated for chronic hepatitis C (CHC). Materials and methods: The study was conducted in patients with CHC between April 2007 and March 2011, who had achieved SVR following treatment. They were treated with PEG IFN-α and ribavirin. Patients, whose e...

Compliance with follow-up after occupational exposure to hepatitis C.

BACKGROUND Accidental percutaneous exposure to blood containing hepatitis C virus (HCV) is reported by health care workers more frequently than exposure to human immunodeficiency and hepatitis B virus. The transmission rate following such an exposure is approximately 1.9%. Little is known about the attendance rate of such staff for follow-up testing following exposure to HCV. AIM To determine...

The results of six months follow up in patients with subclinical thyrotoxicosis

Introduction: There is no definite treatment for subclinical hyperthyroidism which is defined as suppressed TSH and normal T3 and T4 levels. In this study, patients with subclinical hyperthyroidism were followed for 6 months without any medical treatment. Methods: A total number of 285 patients of individuals who participated in Tehran glucose and lipid study and had TSH≤0.3 mu/l and normal T...

immune response to hepatitis b vaccine in patients who lost hepatitis b surface antigen during follow up